Cargando…
Exendin-4 Prevents Vascular Smooth Muscle Cell Proliferation and Migration by Angiotensin II via the Inhibition of ERK1/2 and JNK Signaling Pathways
Angiotensin II (Ang II) is a main pathophysiological culprit peptide for hypertension and atherosclerosis by causing vascular smooth muscle cell (VSMC) proliferation and migration. Exendin-4, a glucagon-like peptide-1 (GLP-1) receptor agonist, is currently used for the treatment of type-2 diabetes,...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574935/ https://www.ncbi.nlm.nih.gov/pubmed/26379274 http://dx.doi.org/10.1371/journal.pone.0137960 |
_version_ | 1782390693178638336 |
---|---|
author | Nagayama, Kosuke Kyotani, Yoji Zhao, Jing Ito, Satoyasu Ozawa, Kentaro Bolstad, Francesco A. Yoshizumi, Masanori |
author_facet | Nagayama, Kosuke Kyotani, Yoji Zhao, Jing Ito, Satoyasu Ozawa, Kentaro Bolstad, Francesco A. Yoshizumi, Masanori |
author_sort | Nagayama, Kosuke |
collection | PubMed |
description | Angiotensin II (Ang II) is a main pathophysiological culprit peptide for hypertension and atherosclerosis by causing vascular smooth muscle cell (VSMC) proliferation and migration. Exendin-4, a glucagon-like peptide-1 (GLP-1) receptor agonist, is currently used for the treatment of type-2 diabetes, and is believed to have beneficial effects for cardiovascular diseases. However, the vascular protective mechanisms of GLP-1 receptor agonists remain largely unexplained. In the present study, we examined the effect of exendin-4 on Ang II-induced proliferation and migration of cultured rat aortic smooth muscle cells (RASMC). The major findings of the present study are as follows: (1) Ang II caused a phenotypic switch of RASMC from contractile type to synthetic proliferative type cells; (2) Ang II caused concentration-dependent RASMC proliferation, which was significantly inhibited by the pretreatment with exendin-4; (3) Ang II caused concentration-dependent RASMC migration, which was effectively inhibited by the pretreatment with exendin-4; (4) exendin-4 inhibited Ang II-induced phosphorylation of ERK1/2 and JNK in a pre-incubation time-dependent manner; and (5) U0126 (an ERK1/2 kinase inhibitor) and SP600125 (a JNK inhibitor) also inhibited both RASMC proliferation and migration induced by Ang II stimulation. These results suggest that exendin-4 prevented Ang II-induced VSMC proliferation and migration through the inhibition of ERK1/2 and JNK phosphorylation caused by Ang II stimulation. This indicates that GLP-1 receptor agonists should be considered for use in the treatment of cardiovascular diseases in addition to their current use in the treatment of diabetes mellitus. |
format | Online Article Text |
id | pubmed-4574935 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-45749352015-09-25 Exendin-4 Prevents Vascular Smooth Muscle Cell Proliferation and Migration by Angiotensin II via the Inhibition of ERK1/2 and JNK Signaling Pathways Nagayama, Kosuke Kyotani, Yoji Zhao, Jing Ito, Satoyasu Ozawa, Kentaro Bolstad, Francesco A. Yoshizumi, Masanori PLoS One Research Article Angiotensin II (Ang II) is a main pathophysiological culprit peptide for hypertension and atherosclerosis by causing vascular smooth muscle cell (VSMC) proliferation and migration. Exendin-4, a glucagon-like peptide-1 (GLP-1) receptor agonist, is currently used for the treatment of type-2 diabetes, and is believed to have beneficial effects for cardiovascular diseases. However, the vascular protective mechanisms of GLP-1 receptor agonists remain largely unexplained. In the present study, we examined the effect of exendin-4 on Ang II-induced proliferation and migration of cultured rat aortic smooth muscle cells (RASMC). The major findings of the present study are as follows: (1) Ang II caused a phenotypic switch of RASMC from contractile type to synthetic proliferative type cells; (2) Ang II caused concentration-dependent RASMC proliferation, which was significantly inhibited by the pretreatment with exendin-4; (3) Ang II caused concentration-dependent RASMC migration, which was effectively inhibited by the pretreatment with exendin-4; (4) exendin-4 inhibited Ang II-induced phosphorylation of ERK1/2 and JNK in a pre-incubation time-dependent manner; and (5) U0126 (an ERK1/2 kinase inhibitor) and SP600125 (a JNK inhibitor) also inhibited both RASMC proliferation and migration induced by Ang II stimulation. These results suggest that exendin-4 prevented Ang II-induced VSMC proliferation and migration through the inhibition of ERK1/2 and JNK phosphorylation caused by Ang II stimulation. This indicates that GLP-1 receptor agonists should be considered for use in the treatment of cardiovascular diseases in addition to their current use in the treatment of diabetes mellitus. Public Library of Science 2015-09-17 /pmc/articles/PMC4574935/ /pubmed/26379274 http://dx.doi.org/10.1371/journal.pone.0137960 Text en © 2015 Nagayama et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Nagayama, Kosuke Kyotani, Yoji Zhao, Jing Ito, Satoyasu Ozawa, Kentaro Bolstad, Francesco A. Yoshizumi, Masanori Exendin-4 Prevents Vascular Smooth Muscle Cell Proliferation and Migration by Angiotensin II via the Inhibition of ERK1/2 and JNK Signaling Pathways |
title | Exendin-4 Prevents Vascular Smooth Muscle Cell Proliferation and Migration by Angiotensin II via the Inhibition of ERK1/2 and JNK Signaling Pathways |
title_full | Exendin-4 Prevents Vascular Smooth Muscle Cell Proliferation and Migration by Angiotensin II via the Inhibition of ERK1/2 and JNK Signaling Pathways |
title_fullStr | Exendin-4 Prevents Vascular Smooth Muscle Cell Proliferation and Migration by Angiotensin II via the Inhibition of ERK1/2 and JNK Signaling Pathways |
title_full_unstemmed | Exendin-4 Prevents Vascular Smooth Muscle Cell Proliferation and Migration by Angiotensin II via the Inhibition of ERK1/2 and JNK Signaling Pathways |
title_short | Exendin-4 Prevents Vascular Smooth Muscle Cell Proliferation and Migration by Angiotensin II via the Inhibition of ERK1/2 and JNK Signaling Pathways |
title_sort | exendin-4 prevents vascular smooth muscle cell proliferation and migration by angiotensin ii via the inhibition of erk1/2 and jnk signaling pathways |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574935/ https://www.ncbi.nlm.nih.gov/pubmed/26379274 http://dx.doi.org/10.1371/journal.pone.0137960 |
work_keys_str_mv | AT nagayamakosuke exendin4preventsvascularsmoothmusclecellproliferationandmigrationbyangiotensiniiviatheinhibitionoferk12andjnksignalingpathways AT kyotaniyoji exendin4preventsvascularsmoothmusclecellproliferationandmigrationbyangiotensiniiviatheinhibitionoferk12andjnksignalingpathways AT zhaojing exendin4preventsvascularsmoothmusclecellproliferationandmigrationbyangiotensiniiviatheinhibitionoferk12andjnksignalingpathways AT itosatoyasu exendin4preventsvascularsmoothmusclecellproliferationandmigrationbyangiotensiniiviatheinhibitionoferk12andjnksignalingpathways AT ozawakentaro exendin4preventsvascularsmoothmusclecellproliferationandmigrationbyangiotensiniiviatheinhibitionoferk12andjnksignalingpathways AT bolstadfrancescoa exendin4preventsvascularsmoothmusclecellproliferationandmigrationbyangiotensiniiviatheinhibitionoferk12andjnksignalingpathways AT yoshizumimasanori exendin4preventsvascularsmoothmusclecellproliferationandmigrationbyangiotensiniiviatheinhibitionoferk12andjnksignalingpathways |